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Summary, Conclusions, and Recommendations
Suvvanv
After the introduction of so-called technical-variant liver transplantations, waiting list time
and waiting list mortalify for pediatric patients with an end-stage liver disease have
decreased. Despite these new techniques, which include transplantation of reduced-size and
split liver grafts, there is still scarcity of donor organs for pediatric patients. Additionally,
pediatric liver transplantation is still hampered by patient and graft loss. The aim of this
thesis was to identify factors that affect the outcome of pediatric liver transplantation in
terms of patient and graft survival and morbidity. Studies were based on the experience of
the University Hospital Groningen, where since 1982 more than 160 liver transplantations
in children were performed.
Patient survival after pediatric liver transplantation has improved considerably during the
last decades. However, still a considerable number of children die after transplantation. In
Chapter .I1, long-term actual patient survival after transplantation was analyzed and risk
factors for such survival rates were identified in a series of 66 children who had or could
have had a follow-up of at least five years. One, three, and five-year patient survival rates
were 867o, l9oÁ, and73%o,respectively. Risk factors affecting patient survival proved to be
a high Child-Pugh score, a high donor age, high blood loss, and retransplantation. A high
blood loss was correlated with biliary atresia, low recipient age and weight, and with
previous surgery. The duration of the stay of the donor at the intensive care unit was a
predictive factor for retransplantation. It was concluded that children with diseases eligible
for liver transplantation should be referred early in the course of their disease to a
transplantation center. Furthermore, during the transplantation procedure, all possible
measures should be taken to keep the blood loss at a minimum. Children with biliary atresia
deserve special attention in this respect. Finally, the choice of donors has implications for
long-term survival after pediatric liver transpiantation. Grafts from younger donors have a
favorable impact on survival. In clinical practice this may implicate that regarding the
choice of the donor, the age of the donor should be as close to the recipient's age as
possible. Choosing donors with a short ICU-stay can reduce the retransplantation rate and
consequently improve patient survival.
Graft failure after liver transplantation is still an important problem. It results in death of the
recipient or in retransplantation, with subsequently lower survival rates. The epidemiology
and causes of graft loss after 157 transplantations performed in 120 children were described
rn Chapter 111. Furthermore, risk factors for graft loss were identified in this chapter.
Overall one, three, and five-year patient survival was 82oÁ,77oÁ, and 7loÁ, rcspectively. For
graft survival these rates were 64yo, 59'yo, and 53oÁ, respectively. Seventy-one of 157 (45%)
grafts were lost: 18 (25%)by death of patients with functioning grafts and 53 (75%)by
graft related complications. Forty-five (630Á) grafts were lost early after transplantation
(i.e., loss within one month after transplantation). Main causes of these early losses were
vascular complications, primary nonfunction, and death of patients with well functioning
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grafts. A high Child-Pugh score, a prolonged duration of the anhepatic phase, and urgent
transplantations proved to be risk factors for early graft loss. Main causes of late graft loss
were fibrosis or cirrhosis. A high donor age, a high donor/recipient weight ratio, high blood
loss, and technical-variant liver grafts were risk factors for late graft loss. In conclusion, to
prevent graft loss after pediatric liver transplantation, potential recipients should be referred
early to a lransplantation center to transplant them in an earlier phase of their disease.
Furthermore, substantial age and weight discrepancies between the donor and recipient
should be omitted. Finally, the logistics of the operation need to be optimal to keep the
anhepatic phase as short as possible.
Because of the poor outcome of hepatic retransplantation, it is still debated whether this
procedure should be performed in an era of donor organ scarcity.InChapter 12, a series of
97 children after a single transplantation was compared with 34 children with one
retransplantation. The outcome after retransplantation was evaluated, risk factors were
identified, and morbidiry and causes of death were analyzed. It 'aras revealed that patient
survival after retransplantation was significantly lower compared with survival of children
with a single transplantation. However, this was due to low survival after retransplantation
within one month after primary transplantation. Survival of children who received a
retransplant nrore than one month after primary transplantation was not different from
survival after single transplantation. In early retransplantations, the Child-Pugh score was
higher, donors were older and weighed more, and more technical-variant liver grafts were
used compared with single transplantations. Biliary atresia and a high Child-Pugh score
were associated with decreased patient survival after retransplantation. Sepsis was the most
important complication and cause of death after retransplantation. It was concluded that
retransplantation was a significant event after pediatric liver transplantation. The outcome
after hepatic retransplantation in children was inferior compared with single transplantation
and was caused by low survival after early retransplantation. This could be explained by the
poor clinical condition of the children at time of early retransplantation, especially in
children with biliary atresia, and by the predominant use of technical-variant liver grafts.
In Chapter Z, the incidence and consequences of hepatic artery thrombosis, portal vein
thrombosis, and venous outflow tract obstruction in a consecutive series of 157 pediatric
liver transplantations \Mere assessed and analyzed. Furthermore, risk factors for these
compiications were identified. The overall incidence of vascular complications was 27o/o.
The incidence of hepatic arlery thrombosis, portal vein thrombosis, and venous outflow
tract obslruction was l0%, 5%, and 6oÁ, respectively. Patient survival after portal vein
thrombosis and venous outflow tract obshuction was lower compared with survival of
children without vascular complications. Graft survival after hepatic artery thrombosis and
portal vein thrombosis was lower compared with survival of grafts without vascular
complications. A low donor/recipient age ratio, a long operation time, and the use of the
recipient's bifurcation of the proper hepatic artery for anastomosis were risk factors for
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Summarn, Conclusions, and Recommendations
technique were risk factors for portal vein thrombosis. Fulminant hepatic failure, a high
donor/recipient age and weight ratio, and segmental grafts were risk factors for venous
outflow tract obstruction. It was concluded that vascular complications, which occurred in
21%" of pediatric liver transplants, had a significant impact on patient and graft survival.
Vascular complications originate either from a combination of small donors and small
recipients or from size disparity between donors and recipients. Patient and graft survival
might improve by avoiding the identified risk factors.
To alleviate the shortage of size-matched whole-donor organs, adult donor grafts are
modified by liver resection techniques. These modifications result in technical-variant liver
transplantation. Patient and graft survival rates after technical-variant liver transplantation
are considered comparable to those after full-size liver transplantation. However, morbidity
after technical-variant liver transplantation is often underexposed. Survival and morbidity
after full-size liver transplantation was compared with techlical-variant liver transplantation
it Chapter ZL Forty-seven children underwent a primary and elective full-size liver
transplantation and 50 a primary and elective technical-variant liver transplantation (38
reduced-size liver grafts and 12 split liver grafts). Patient and graft survival rates were not
different between full-size and technical-variant liver transplantation. However, after
technical-variant liver transplantation there was a significantly higher complication rate.
Technical-variant liver transplantation was hampered by more biliary complications, like
cholangitis and bile leakage, compared with full-size transplantation. These complications
led to a higher incidence of sepsis and a higher intervention rate after technical-variant liver
transplantation. The incidence of retransplantations was not different between full-size and
techlical-variant liver transplantation. In conclusion, full-size and technical-variant liver
transplantation offered the same prognosis in tems of patient and graft survival for children
after a primary and elective liver transplantation. However, technical-variant liver
transplantation had a higher morbidity.
Despite the advantages of split liver hansplantation concerning waiting list time and waiting
list mortality, there is still restraint for using this technique.In Chapter VII, our experience
with split liver transplantation was evaluated. Survival was analyzed and compared with
full-size and reduced-size liver transplantation and morbidity and causes of death were
assessed. Twenty-seven split liver hansplantations were performed in 16 children and nine
adults. In children, patient and graft survival after split liver transplantation was lower
compared with full-size liver transplantation but not different from reduced-size liver
transplantation. In adults, patient and graft survival after split liver transplantation was
lower compared with full-size liver transplantation. Morbidity after pediatric split liver
transplantation was not different from reduced-size liver transplantation. However, more
grafts had to be retransplanted after split liver transplantation. The urgency of the
transplantation and the cold ischemia time seemed prognostic factors for the outcome of
split liver transplantation. In conclusion, this chapter elucidated the pitfalls of a split liver
program and indicated several measures to improve the results of this intrinsically
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promising procedure. Careful selection of recipients and donors and streamlined logistics
will probably improve the outcome.
Recent histopathological studies showed an unexpected high incidence of portal fibrosis in
asymptomatic survivors after pediatric liver transplantation. In Chapter VIII, the
occurrence, risk factors, and consequences of portal fibrosis on liver function tests were
analyzed. The incidence of mild to severe portal fibrosis in the frrst annual protocol graft
biopsies of 84 consecutive liver transplants was 3l%o. All liver function tests, except the
albumin level, showed an increase in the group with portal fibrosis compared with the group
without portal fibrosis. Mean values of alkaline phosphatase and direct bilirubin were
significantly higher in children with portal fibrosis. A positive conelation with portal
fibrosis was found for the cold ischemia time, biliary complications, and the
cytomegalovirus status of the recipient. Acute rejection showed a negative correlation with
portal fibrosis. In conclusion, portal fibrosis within one year post liver transplantation was a
significant problem after pediatric liver transplantation. It was accompanied by cholestatic
liver function test abnormalities. Factors predisposing to portal fibrosis were a prolonged
cold ischemia time, biliary complications, and a positive cytomegalovirus status of the
recipient at time of transplantation. Acute rejection seemed to prevent portal fibrosis.
Prospective HLA matching between donor and recipient and crossmatching are not
routinely performed before liver transplantation. However, reconsideration of these
procedures in liver transplantation may be justified, especially in pediatric recipients. In
Chapter 1X, the influence of HLA matching, both at the level of antigens and cross-reactive
antigen groups, and crossmatches of autoantibodies cin survival after pediatric
transplantation was analyzed. Furthermore, the occunence of acute rejection within three
months and portal fibrosis within one year after transplantation was related to the results of
these matching procedures. A distinction was made between graft types. HLA typings of
105 transplants and crossmatches of autoantibodies of 98 transplants were analyzed. It was
revealed that HLA matching and matching for autoantibodies did not influence overall graft
survival. Survival of technical-variant grafts was better in case of two mismatches at the
HLA-DR locus compared to zero or one mismatch. The matching procedures did neither
influence the overall incidence of early acute rejection or the incidence of early acute
rejection after full-size or technical-variant liver transplantation. Matching for HLA-DR
proved to be a risk factor for the development of portal fibrosis. It was concluded that a
beneficial effect of HLA matching, sharing cross-reactive antigen groups, or matching of
autoantibodies could not be observed. A negative effect of HLA-DR matching on survival
of technical-variant grafts was found. It was assumed that this was caused by the higher
incidence ofportal fibrosis in these grafts.
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